TABLE 4.

Longitudinal Studies of Anxiety in Patients with Prostate Carcinoma

Study	Measure	Time 1	Time 2	Anxiety levels
Screening
Davison et al., 199930	STAI	Prescreen	Postscreen, unknown result	No change
Taylor et al., 200223	IES	Prescreen	Postscreen, normal result	Decrease
Essink-Bot et al., 199821	STAI	Prescreen	Postscreen, normal result	Decrease
Cormier et al., 200227	STAI	Prescreen	Postscreen, normal result	Decrease
Gustafsson et al., 199544	Serum cortisol	Prescreen	Postscreen, normal result	Decrease
Diagnosis
Davison et al., 200346	STAI	At positive biopsy	4 mos later	Decrease
Essink-Bot et al., 199821	STAI	Postscreen, abnormal result	Postbiospy, unknown result	No change
Essink-Bot et al., 199821	STAI	Postbiopsy, unknown result	Postbiospy, normal result	Decrease
Gustafsson et al., 199544	Serum cortisol	Postscreen, abnormal result	16 weeks later	No change
Nordin et al., 200145	HADS	At positive biopsy	6 mos later	Decrease
Treatment
Bisson et al., 200231	HADS	Localized disease, first visit	Two weeks after first visit	Decrease
Bisson et al., 200231	IES	Localized disease, first visit	Two weeks after first visit	No change
Helgesen et al., 200047	HADS	Postdiagnosis or during treatment	Annually for 3 yrs	No change

STAI: State-Trait Anxiety Inventory; IES: Impact of Event Scale; HADS: Hospital Anxiety and Depression Scale.